All
Dermatology’s Carbon Footprint Under the Microscope
Explore the urgent need for sustainability in dermatology, addressing its environmental impact and advocating for eco-friendly practices in health care.
Botulinum Toxin A and Hyaluronic Acid Reduce Acne-Caused Enlarged Pores, New Study Finds
A study reveals that combining botulinum toxin A and hyaluronic acid significantly reduces acne-related enlarged pores, enhancing skin texture and patient satisfaction.
“Hats On” Challenge Unites Dermatology Community to Spotlight Actinic Keratosis Ahead of Global Awareness Day
The social media campaign aims to educate, inspire prevention, and support actinic keratosis awareness leading up to Global AK Awareness Day on May 24.
The Skin Cancer Foundation Photobiology Committee Announces Updated Criteria for Seal of Recommendation During Skin Cancer Awareness Month
The Photobiology Committee also issues a public safety warning regarding sun protection misinformation amid growing rates of skin cancer in the U.S.
Exploring Varying Doses of Oral Isotretinoin for Facial Warts and its Impact on Quality of Life
A new study reveals the effectiveness of two isotretinoin doses for treating recalcitrant facial flat warts, enhancing quality of life and reducing anxiety.
Frequency-Specific Sound Enhances Tissue Regrowth
Acoustic stimulation using infrasound and low-frequency sound enhances wound healing, promoting cellular activity and tissue repair in innovative, non-invasive ways.
Dermatology Conferences and Meetings Calendar: May 2025
Dermatology Times has compiled a list of dermatological meetings taking place during the month of May.
Daily Derm Times: April 30, 2025
Catch up on dermatology news, highlights, and insights from the past 24 hours.
Expanding Topical Non-Steroidal Options in Atopic Dermatitis to Reduce Chronic Steroid Use
Raj Chovatiya, MD, PhD, MSCI, reviews the limitations of chronic steroid use and highlights available topicals, including ruxolitinib, roflumilast, and tapinarof.
Optimizing Atopic Dermatitis Care With Emerging Topical Therapeutics
At a recent Dermatology Times Case-Based Roundtable event, Lisa Swanson, MD, discussed 3 diverse atopic dermatitis patient cases.
Q32 Bio’s Bempikibart Receives FDA Fast Track Designation for Alopecia Areata
The developement of bempikibart offers hope for effective treatment of severe alopecia areata amid unmet medical needs.
JAKi and IL-4/-13i Show Similar Safety Profiles in AD
New research reveals JAK inhibitors for atopic dermatitis do not increase cardiovascular or cancer risks compared to IL-4/-13 inhibitors, offering reassurance for patients.
Celebrating Rosacea Awareness Month 2025 with Dermatology Times
Explore the latest insights, strategies, and treatments for patients with rosacea as Dermatology Times looks back on Rosacea Awareness Month.
Dermatology Times April 2025 Recap
Dermatology Times is looking back on the top stories in dermatology from the month of April.
Top 5 Articles of the Month: April
Explore the top headlines of the week including insights on recalls, expert pearls, and more.
Journal Digest: April 30
This review of the latest dermatologic studies includes insights into the environmental impact of dermatology, submicrobial dosing of antibiotics in dermatology, and more.
Daily Derm Times: April 29, 2025
Understanding the Role of OX40 in Next-Generation Eczema Therapies
Acting upstream of cytokines may hold the key to improving biologic efficacy and itch relief in AD.
How Does Psoriasis Influence Sun Tanning Addiction?
Younger patients with moderate to severe psoriasis exhibit risky sun exposure behaviors, raising concerns about tanning addiction and skin cancer risks.
Interview Intersection: Expert Interviews From April 2025
Dermatology Times is recapping our exclusive expert interviews from the month of April.
Newly Developed Questionnaire Evaluates Quality of Life for Patients with Hair and Scalp Conditions
The innovative 21-item Hair & Scalp CARE questionnaire is designed to evaluate the psychological impact of hair and scalp conditions on quality of life.
FDA Approves First Gene Therapy for RDEB
The FDA approved pz-cel, a groundbreaking gene therapy for recessive dystrophic epidermolysis bullosa, transforming treatment options for patients.
Subgroup Case Series Reveals JAKi Efficacy for Black Patients With AA
JAK inhibitors show promise in treating alopecia areata among Black patients, highlighting the need for inclusive clinical research and equitable access to therapies.
Daily Derm Times: April 28, 2025
Dermatology Times April 2025 Print Recap
Learn more about the in-depth topics covered in the April 2025 print issue of Dermatology Times.
Novel Serum Improves Facial Skin Quality in Patients Using GLP-1 Receptor Agonists
The groundbreaking GLPSGLT serum enhances skin quality for GLP-1 RA users, improving elasticity and reducing wrinkles in just 6 weeks.
Jonathan Silverberg, MD, PhD, MPH on Keeping Up With Rapid AD Developments
Discover cutting-edge insights on atopic dermatitis at RAD 2025, featuring expert discussions and the latest therapies to enhance your practice.
Positive Correlation Between Acne and BMI in Adolescent Patients in Sudan
A new study reveals a significant link between acne prevalence and high BMI in Sudanese adolescents, highlighting gender differences and the need for further research.
The Vicious Cycle of Itch, Stress, and Sleep Loss
Real-World Study Highlights Burden of Moderate to Severe Atopic Dermatitis in Children and Adolescents
A new study reveals ongoing burden of moderate to severe atopic dermatitis in youth, with flares, comorbidities, and quality of life impacts.